Maithili A Athavale*

Assistant General Manager (R&D), Cancer Biology Lab (A Unit of Godavari Biorefineries Ltd.), MIDC Mahape, Navi Mumbai, India

*Corresponding Author: Maithili A Athavale, Assistant General Manager (R&D), Cancer Biology Lab (A Unit of Godavari Biorefineries Ltd.), MIDC Mahape, Navi Mumbai, India.

Received: November 22, 2021; Published: December 01, 2021

For a long time scientists and the medical professionals around the world were wondering about the cause of cancer relapse in patients who had responded positively to chemotherapy.

In recent years increasing evidence suggests that cancer originates from a small fraction.

Of tumour initiating cells with the abilities of self-renewal, unlimited propagation, multipotent differentiation and giving rise to phenotypically distinct cells found within the tumour population. Such capabilities share similarity with normal stem cells. Thus these cells are called Cancer Stem Cells (CSC).

The need of the hour is to develop cancer therapy that can kill CSC along with Cancer cells.

Citation

Citation: Maithili A Athavale. “Cancer and Cancer Stem Cells”. Acta Scientific Women's Health 4.1 (2022): 01.

Copyright

Copyright: © 2022 Maithili A Athavale. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.